Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Leukemia × tipifarnib × Clear all

Phase

Status

Completed 4 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Carcinoma, Transitional Cell 1

Interventions

Cytarabine 35 Cyclophosphamide 24 Radiotherapy 17 Etoposide 17 Daunorubicin 16 Busulfan 15 Methotrexate 14 Idarubicin 14 Peripheral Blood Stem Cell Transplantation 13 Mercaptopurine 12 Dexamethasone 12 Vincristine 11 Thioguanine 9 pegaspargase 8 Mitoxantrone 8 Doxorubicin 8 Antilymphocyte Serum 8 fludarabine phosphate 7 Filgrastim 7 Asparaginase 7 Prednisone 6 Prednisolone 6 Polymerase Chain Reaction 6 Cyclosporine 6 Mycophenolic Acid 5 Melphalan 5 Gene Expression Profiling 5 Leucovorin 4 Imatinib Mesylate 4 Ifosfamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510939 2009-08-14

HEMOS AML 0106

University of Bologna

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡